Jim Cramer backs AST SpaceMobile as a speculative buy, calls NuScale Power too risky, praises Medline as top IPO.

On CNBC's Mad Money, Jim Cramer recommended AST SpaceMobile as a promising speculative stock with potential gains in two years, noting its upcoming satellite launches. He described NuScale Power as too speculative but favored GE Vernova for safety. Cramer also praised Medline as probably the best IPO of the year, with the company set to report Q2 earnings on August 5. These insights highlight varied investor risk appetites and upcoming earnings events to watch.